Status:
COMPLETED
Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic
Lead Sponsor:
Institut Cancerologie de l'Ouest
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Covid-19 has, in a few weeks, made the world tremble: the number of deaths (mainly elderly and / or co-morbid) continues to increase, the confinement causes the collapsing of the economy and the d...
Detailed Description
The participation of the study will be offered to each patient when they will come to the centre (by oncologist, radiotherapist, surgeon, ...). For the health staff, the information can be delivered t...
Eligibility Criteria
Inclusion
- Age \>= 18 years
- Population in Cancer centres responding to one of these 3 definitions: patients having a treatment in process, patients under surveillance ( having completed their treatment for more than a year), health staff.
- Subjects who may or may not have had an infection compatible or proven with a Covid-19 infection.
- Information to the participants and signature of the informed consent.
- Subject affiliated with a social insurance
Exclusion
- Refusal of consent
- Patients who are unable to consent or have a psychiatric history
- Inability to submit to the medical follow-up of the study for geographical, social or psychological reasons
- Person under guardianship or protection of vulnerable adults
- Person deprived of liberty by a judicial or administrative decision
Key Trial Info
Start Date :
June 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 28 2022
Estimated Enrollment :
1102 Patients enrolled
Trial Details
Trial ID
NCT04421625
Start Date
June 15 2020
End Date
June 28 2022
Last Update
December 30 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de Cancerologie de l'Ouest
Angers, France, 49055
2
Centre Jean Perrin
Clermont-Ferrand, France, 63011
3
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, France, 54511